TradingKey

关于 Treace Medical Concepts Inc 公司

Treace Medical Concepts, Inc. 是一家医疗技术公司。该公司致力于提高拇囊炎和相关中足畸形的外科治疗标准。该公司已获得 Lapiplasty 3D 拇囊炎矫正系统的专利，该系统结合了器械、植入物和手术方法，旨在通过手术矫正拇囊炎畸形的所有三个平面并固定不稳定的关节，解决拇囊炎的根本原因并帮助患者恢复积极的生活方式。该公司还拥有 Adductoplasty 中足矫正系统，旨在对中足进行可重复的外科矫正，以及锤状趾 PEEK 固定系统，旨在解决锤状趾、爪形趾和槌状趾畸形。Lapiplasty、Adductoplasty 和锤状趾 PEEK 固定系统由一次性植入物套件和可重复使用的器械托盘组成。该公司将这些产品出售给美国的医生、外科医生、医院和门诊手术中心。

公司简介

公司代码TMCI

公司名称Treace Medical Concepts Inc

上市日期Apr 23, 2021

CEOMr. John T. Treace

员工数量477

证券类型Ordinary Share

年结日Apr 23

公司地址100 Palmetto Park Place

城市PONTE VEDRA

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编32081

电话19043735940

网址https://www.treace.com/

公司代码TMCI

上市日期Apr 23, 2021

CEOMr. John T. Treace

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Richard W. Mott

Lead Independent Director

1.10M

+2.23%

Mr. John K. Bakewell

Independent Director

516.36K

+4.86%

Dr. Sean F. Scanlan, Ph.D.

Chief Innovation Officer

72.42K

+85.77%

Mr. Scot Michael Elder

Chief Legal & Compliance Officer, Corporate Secretary

53.38K

+12.38%

Mr. Lance A. Berry, CPA

Independent Director

40.90K

+140.86%

Mr. Gaetano Guglielmino

Chief Commercial Officer

--

Mr. John T. Treace

Chairman of the Board, Chief Executive Officer, Founder

--

Mr. Aaron J. Berutti

Senior Vice President - Sales

--

Mr. Mark L. Hair

Chief Financial Officer

--

Ms. Lynn Lewis

Investor Relations

--

名称

名称/职务

职务

持股

持股变动

Mr. Richard W. Mott

Lead Independent Director

1.10M

+2.23%

Mr. John K. Bakewell

Independent Director

516.36K

+4.86%

Dr. Sean F. Scanlan, Ph.D.

Chief Innovation Officer

72.42K

+85.77%

Mr. Scot Michael Elder

Chief Legal & Compliance Officer, Corporate Secretary

53.38K

+12.38%

Mr. Lance A. Berry, CPA

Independent Director

40.90K

+140.86%

Mr. Gaetano Guglielmino

Chief Commercial Officer

--

收入明细

暂无数据

暂无数据

业务

地区

暂无数据

股东统计

更新时间: 5月17日周六

持股股东

股东类型

持股股东

占比

Treace (John T.)

18.61%

Armistice Capital LLC

9.87%

BlackRock Institutional Trust Company, N.A.

5.41%

William Blair Investment Management, LLC

4.93%

The Vanguard Group, Inc.

4.30%

Other

56.88%

持股股东

占比

Treace (John T.)

18.61%

Armistice Capital LLC

9.87%

BlackRock Institutional Trust Company, N.A.

5.41%

William Blair Investment Management, LLC

4.93%

The Vanguard Group, Inc.

4.30%

Other

56.88%

股东类型

持股股东

占比

Individual Investor

25.90%

Investment Advisor/Hedge Fund

21.15%

Investment Advisor

19.72%

Hedge Fund

17.61%

Research Firm

3.05%

Bank and Trust

0.34%

Sovereign Wealth Fund

0.10%

Pension Fund

0.04%

Insurance Company

0.03%

Other

12.07%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

369

55.31M

87.93%

-19.85M

2025Q1

378

54.40M

86.48%

-21.10M

2024Q4

366

54.35M

86.91%

-21.27M

2024Q3

360

58.92M

95.05%

-18.98M

2024Q2

346

57.87M

93.51%

-12.18M

2024Q1

319

59.01M

95.72%

-10.84M

2023Q4

318

57.97M

94.48%

-4.76M

2023Q3

299

57.85M

94.48%

-5.12M

2023Q2

290

57.64M

94.33%

-3.44M

2023Q1

265

55.41M

90.97%

+228.07K

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Treace (John T.)

11.70M

18.61%

-159.07K

-1.34%

Mar 24, 2025

Armistice Capital LLC

6.21M

9.87%

+2.00K

+0.03%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.40M

5.41%

+14.71K

+0.43%

Mar 31, 2025

William Blair Investment Management, LLC

3.06M

4.87%

+121.76K

+4.14%

Mar 31, 2025

The Vanguard Group, Inc.

2.71M

4.3%

-27.56K

-1.01%

Mar 31, 2025

CIBC Private Wealth Management

2.29M

3.65%

+405.26K

+21.46%

Mar 31, 2025

Gagnon Securities LLC

2.71M

4.31%

+963.43K

+55.16%

May 09, 2025

Treace (James T)

1.78M

2.83%

--

Mar 24, 2025

JP Morgan Asset Management

1.40M

2.22%

-93.94K

-6.29%

Mar 31, 2025

DWS Investments UK Limited

1.28M

2.04%

-4.96K

-0.39%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

Franklin US Small Cap Multifactor Index ETF

0.04%

iShares U.S. Medical Devices ETF

0.03%

Fidelity Enhanced Small Cap ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

Global X Russell 2000 ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

Invesco Russell 2000 Dynamic Multifactor ETF

0.01%

Proshares Ultra Russell 2000

0.01%

ProShares Hedge Replication ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Franklin US Small Cap Multifactor Index ETF

占比0.04%

iShares U.S. Medical Devices ETF

占比0.03%

Fidelity Enhanced Small Cap ETF

占比0.02%

iShares Russell 2000 Growth ETF

占比0.02%

Global X Russell 2000 ETF

占比0.01%

Schwab U.S. Small-Cap ETF

占比0.01%

Invesco Russell 2000 Dynamic Multifactor ETF

占比0.01%

Proshares Ultra Russell 2000

占比0.01%

ProShares Hedge Replication ETF

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Treace Medical Concepts Inc

5.470USD

Treace Medical Concepts Inc

5.470

概览

公司

财务